Target intelligence / Profile preview

Positively charged proteins

Molecular classification
Other
01

Overview

Positively charged proteins, also known as cationic proteins, are a broad class of proteins characterized by a high isoelectric point (pI) due to an abundance of basic amino acids such as arginine and lysine [1]. This category includes diverse molecules such as histones, which package DNA, and eosinophil-derived proteins like Eosinophil Cationic Protein (ECP) and Major Basic Protein (MBP), which play roles in the immune response against parasites but can also cause tissue damage in allergic diseases like asthma [2]. Because of their strong positive charge, these proteins interact electrostatically with negatively charged molecules, including cell surface glycosaminoglycans and nucleic acids [3]. In a therapeutic context, polyanionic drugs like heparin are often used to neutralize the toxic effects of certain cationic proteins or to interfere with their biological signaling [4]. However, 'positively charged proteins' is considered a descriptive category rather than a specific, well-defined therapeutic target for drug development [5]. [1] Alberts B, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. [2] Rothenberg ME, Hogan SP. 'The eosinophil.' Annu Rev Immunol. 2006;24:147-74. [3] Xu J, et al. 'Extracellular histones are major mediators of death in sepsis.' Nat Med. 2009;15(11):1318-21. [4] 'Heparin Sodium.' FDA Label / DailyMed. [5] 'Protamine Sulfate.' StatPearls [Internet].

Other names
Cationic proteinsBasic proteinsPolycationic proteins
02

Mechanism of action

Electrostatic neutralization and sequestration of cationic charges to inhibit biological activity or toxicity.

03

Biological functions

DNA packagingInflammatory responseAntimicrobial activityCell adhesion
04

Disease associations

AsthmaSepsisAllergic inflammationCoagulopathy
05

Safety considerations

Non-specific binding to physiological polyanionsRisk of systemic anticoagulationPotential for anaphylactic reactions to neutralizing agents like protamine
06

Interacting drugs

Heparin

4 more in the full profile.

07

Biomarkers

Eosinophil cationic protein (ECP)Major basic protein (MBP)Circulating cell-free histones

Beyond the preview

Go deeper on Positively charged proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Positively charged proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call